Summit Midstream Parnters (SMLP)

[l_winthorpe]

Yeah, I am excited about it as well.

[catdaddyrt]

STEADY MONEY IMO


http://phx.corporate-ir.net/phoenix.zhtml?c=251398&p=irol-dividends

[catdaddyrt]

I may start-- looking into Summit as we speak I like what I see so far

[l_winthorpe]

Does anyone still post on this board? Came across them on SA and thought that they deserved a second look.

https://seekingalpha.com/article/4122825-12-percent-yield-rising-coverage-record-income-midstream-lp?li_source=LI&li_medium=liftigniter-widget

[mirza3]

In at 21.75...long to 25 or 26..
25k.

[Timothy Smith]

Energy Capital Partners is seeking buyers for its interest in Summit Midstream Partners (SMLP -4.2%), a deal that would include a minority stake in the pipeline operator as well as ownership of its general partner, Bloomberg reports.

The P-E firm reportedly is working with Barclays to find a buyer for the assets, which could fetch at least $2B.

Energy Capital indirectly owns ~44% limited partnership interest in SMLP.

[Timothy Smith]

A deteriorating macro energy macro environment is posing challenges to growth, writes Baird's Ethan Bellamy, downgrading Summit Midstream Partners (SMLP -2.4%) to Neutral, with price target cut to $26 from $39.

[Timothy Smith]

Summit Midstream Partners' (SMLP) CEO Steve Newby on Q2 2015 Results - Earnings Call Transcript $SMLP
http://www.seekingalpha.com/article/3415006

[Timothy Smith]

Summit Midstream Partners (SMLP -1.5%) is initiated with a Buy rating and $42 fair value estimate at Janney, which sees distributions growing at 10%-plus/year, faster than investors appear to expect.

[Timothy Smith]

Wunderlich expects Utica to be the next leg of SMLP's growth, seeing the first dropdown of Utica assets in H2 with more to come in 2016; the firm believes management may structure drops to improve accretion to the LP, which could improve sentiment, as could any new acreage dedications in the Utica.

[Timothy Smith]

Summit Midstream Partners (SMLP +2.8%) is initiated with a Buy rating and $37 price target at Wunderlich, which says concerns of "orphan risk" are overdone, although the firm admits it is impossible to rule out a sale of the GP, Summit Investments, in the current environment.